Analyst Ratings January 28, 2026

Canaccord Reaffirms Buy on Stride as Platform Stabilizes and Q2 Beats Estimates

Analyst keeps $125 target after fiscal Q2 results show enrollment and revenue in line, profitability ahead of consensus and platform issues returning to normal

By Marcus Reed LRN
Canaccord Reaffirms Buy on Stride as Platform Stabilizes and Q2 Beats Estimates
LRN

Canaccord Genuity has reiterated a Buy rating on Stride Inc. (LRN) and kept a $125.00 price target following the company’s fiscal second-quarter results. The target implies roughly 73% upside versus the current share price of $72.43. Stride delivered revenue and enrollment broadly in line with expectations while reporting profitability above consensus, and management says core platform problems have been addressed with metrics normalizing by January.

Key Points

  • Canaccord Genuity reiterated a Buy rating on Stride (LRN) with a $125.00 price target, implying roughly 73% upside from $72.43.
  • Fiscal Q2 results showed total enrollment and revenue broadly in line with expectations while profitability exceeded consensus; EPS was $2.50 versus the $2.01 estimate and revenue was $631.3 million versus $627.9 million expected.
  • Core platform issues have been addressed, with withdrawal rates and customer support requests falling through the quarter and normalizing by January; Stride plans a gradual rollout of an updated student-focused user experience.

Overview

Canaccord Genuity maintained a Buy rating on Stride Inc. (NYSE: LRN) and reaffirmed a $125.00 price target after the company published fiscal Q2 results. That price target represents approximately a 73% premium to the trading price of $72.43 at the time the analyst commentary was noted. According to InvestingPro data, analyst targets for the stock range from $75 to $125, with the consensus suggesting the shares trade below their Fair Value.

Quarterly results and operational context

Stride reported a fiscal Q2 in which total enrollment and revenue came in broadly consistent with expectations, while profitability exceeded the consensus. Growth was muted as the company intentionally limited enrollment while it worked through technology implementation challenges that emerged at the start of the school year. Management indicated that application volumes have remained healthy and were not materially affected by the technical issues, implying stable demand for the company’s virtual education offerings.

Stride also disclosed that it has resolved the core issues with its platform. The company said withdrawal rates and customer support requests declined over the quarter and returned to normal historical ranges by January. Management outlined plans to introduce an updated user experience over the coming months focused on student ease of use, with changes to be implemented gradually after appropriate testing.

Financial position and margins

Despite the operational headwinds from the platform upgrade, Stride has retained strong financial metrics. Revenue over the last twelve months reached $2.52 billion, and the company posted a gross profit margin of 39.3%. InvestingPro analysis highlighted a current ratio of 7.27, indicating substantial liquidity and a balance sheet that holds more cash than debt. That liquidity should provide Stride with the resources to fund ongoing platform improvements.

Management’s guidance for Q3 and fiscal 2026 was broadly in line with expectations, although the company warned that gross margin is expected to decline as it continues to invest in technology.

Market reaction and recent share performance

Shares of Stride had previously dropped sharply following disappointing fiscal Q1 results, when investors feared longer term impacts from the platform upgrade. Canaccord observed that the recovery trajectory appears to be progressing, quoting management as being "cautiously optimistic that the issue is in the past." Still, after the recently reported quarter that beat earnings estimates, the stock experienced a slight decline in after-hours trading.

Earnings highlights

Stride announced second-quarter results for fiscal year 2026 that topped analyst expectations. The company reported earnings per share of $2.50, representing a 24.38% increase versus the projected $2.01. Revenue came in at $631.3 million, slightly above the forecast of $627.9 million. These figures point to stronger near-term profitability even as growth remained constrained by the deliberate enrollment limits and the earlier technology rollover issues.

Analyst context

Canaccord’s maintained Buy stance and $125.00 target sit at the high end of the InvestingPro analyst range of $75 to $125. The divergence between the current market price of $72.43 and the $125.00 target underscores the analyst view that the shares may be materially undervalued relative to Fair Value.

Conclusion

Stride’s fiscal Q2 combined in-line enrollment and revenue with better-than-expected profitability, while management reports platform metrics normalizing after earlier issues. The company’s sizable liquidity position and ongoing technology investments are central to guidance that foresees margin pressure ahead. Canaccord Genuity’s reiteration of a Buy rating and a $125.00 target reflects confidence that the operational problems are being resolved, though the market reaction has been mixed in the immediate term.


Key sectors impacted: Education technology, broader technology services supporting virtual learning, and equity markets covering growth and software-driven education providers.

Risks

  • Gross margin is expected to decline due to ongoing technology investments, which may affect profitability in the near term - this impacts earnings and the technology and education sectors.
  • Earlier platform implementation problems led to a sharp share price drop after fiscal Q1; residual market concerns could continue to influence equity volatility in the education technology sector.
  • Growth has been muted because Stride limited enrollment while fixing technical issues; if enrollment restrictions persist, top-line expansion could remain constrained, affecting revenue growth in the edtech market.

More from Analyst Ratings

Palantir Gains After Lofty 2026 Guidance; Analysts Split on Outlook Feb 2, 2026 Freedom Capital Markets Starts Coverage of Nebius Group With Buy Rating, $108 Target Feb 2, 2026 Clear Street Starts Coverage on Caribou Biosciences with Buy Rating and $13 Target Feb 2, 2026 Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026